Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
15 studies found for:    Pulmonary Embolism | Open Studies | NIH, U.S. Fed
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Twice Daily Enoxaparin Prophylaxis in Reconstructive Surgery Patients
Conditions: Venous Thromboembolism;   Deep Venous Thrombosis;   Pulmonary Embolus
Interventions: Drug: Twice daily enoxaparin prophylaxis;   Drug: Real time dose adjustment
2 Recruiting Nitric Oxide to Treat Pulmonary Embolism
Condition: Pulmonary Embolism
Interventions: Drug: Nitric Oxide + oxygen;   Drug: Nitrogen + Oxygen
3 Recruiting Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease
Conditions: Chronic Kidney Disease;   Pulmonary Embolism;   Renal Artery Stenosis;   Pulmonary Cancer
Interventions: Drug: Low Volume iso-osmolar non-ionic radio contrast medium;   Drug: Acetylcysteine Inhalation;   Drug: Sodium Bicarbonate Solution;   Procedure: 64-MDCT Scanning
4 Recruiting Blood Markers of Inflammation, Blood Clotting and Blood Vessel Function in HIV-infected Adults
Condition: HIV
Intervention:
5 Recruiting Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism
Conditions: Deep Vein Thrombosis;   Malignant Neoplasm;   Portal Vein Thrombosis;   Pulmonary Embolism;   Renal Vein Thrombosis;   Venous Thromboembolism
Interventions: Drug: Apixaban;   Drug: Dalteparin;   Other: Questionnaire Administration
6 Recruiting A Genomic Approach to Warfarin Dose Prescription in Admixed Caribbean Hispanics
Conditions: Atrial Fibrillation;   Deep Vein Thrombosis;   Cardiac Valvular Insufficiency;   Coagulopathies;   Pulmonary Embolism
Interventions: Genetic: Genotype-guided;   Other: Standard-of-Care
7 Recruiting Rituximab and Belimumab for Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Biological: Rituximab;   Drug: Cyclophosphamide;   Drug: Prednisone;   Drug: Methylprednisolone;   Drug: Diphenhydramine;   Drug: Acetaminophen;   Biological: Belimumab
8 Recruiting A Randomized Trial of Induction Versus Expectant Management
Condition: Labor and Delivery
Intervention: Procedure: Elective Induction of Labor
9 Recruiting Prehospital Tranexamic Acid Use for Traumatic Brain Injury
Condition: Traumatic Brain Injury
Interventions: Drug: 1 gram Tranexamic Acid (TXA);   Drug: 2 grams TXA;   Drug: 0.9% Sodium Chloride injectable
10 Recruiting Cancer Associated Thrombosis and Isoquercetin (CAT IQ)
Conditions: Thromboembolism of Vein VTE in Colorectal Cancer;   Thromboembolism of Vein in Pancreatic Cancer;   Thromboembolism of Vein in Non-small Cell Lung Cancer
Intervention: Drug: Isoquercetin
11 Recruiting Patient-Centered Anticoagulation Self-Monitoring in Minority Patients
Conditions: Thromboembolism;   Blood Coagulation Disorders;   Cardiovascular Disease;   Vascular Disease
Intervention: Other: Patient Self-Monitoring vs Anticoagulation Clinic
12 Recruiting Role of 12-lipoxygenase in Platelet Reactivity and Type 2 Diabetes Mellitus
Conditions: Thrombosis;   Type 2 Diabetes Mellitus
Interventions: Dietary Supplement: Primrose oil;   Dietary Supplement: Fish Oil
13 Recruiting Fatty Acid Regulation of Platelet Function in Diabetes
Conditions: Thrombosis;   Type 2 Diabetes Mellitus
Intervention: Other: omega-3 and -6 fatty acids and their 12-LOX oxylipins
14 Not yet recruiting Pediatric High-Risk Deep Venous Thrombosis Lytic Outcomes Trial
Conditions: Deep Vein Thrombosis;   Post-Thrombotic Syndrome;   Venous Thrombosis
Interventions: Drug: Recombinant tissue plasminogen activator (rt-PA);   Drug: Standard Anticoagulation Therapy
15 Recruiting Genetics Informatics Trial (GIFT) of Warfarin to Prevent DVT
Condition: Thromboembolism
Interventions: Genetic: Pharmacogenetic;   Drug: Target INR 1.8

Study has passed its completion date and status has not been verified in more than two years.